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Paracoccidioides brasiliensis is the causative agent of
paracoccidioidomycosis, a disease that affects 10 million
individuals in Latin America. This report depicts the
results of the analysis of 6,022 assembled groups from
mycelium and yeast phase expressed sequence tags, cov-
ering about 80% of the estimated genome of this dimor-
phic, thermo-regulated fungus. The data provide a com-
prehensive view of the fungal metabolism, including
overexpressed transcripts, stage-specific genes, and
also those that are up- or down-regulated as assessed by
in silico electronic subtraction and cDNA microarrays.
Also, a significant differential expression pattern in my-
celium and yeast cells was detected, which was con-
firmed by Northern blot analysis, providing insights
into differential metabolic adaptations. The overall
transcriptome analysis provided information about se-
quences related to the cell cycle, stress response, drug
resistance, and signal transduction pathways of the
pathogen. Novel P. brasiliensis genes have been identi-
fied, probably corresponding to proteins that should be
addressed as virulence factor candidates and potential
new drug targets.
The dimorphic human pathogenic fungus Paracoccidioides
brasiliensis is the etiological agent of paracoccidioidomycosis
(PCM)1 (1), a major health problem in Latin America. High
positive skin tests (75%) in the adult population reinforce the
importance of the mycosis in endemic rural areas, where it has
been estimated to affect around 10 million individuals, 2% of
whom will develop the fatal acute or chronic disease (2). The
acute form of PCM chiefly compromises the reticuloendothelial
system; the chronic form mainly affects adult males with a high
frequency of pulmonary and/or mucocutaneous involvement
(1). Chronic severe multifocal PCM may also cause granuloma-
tous lesions in the central nervous system (3). Regardless of the
affected organ, PCM usually evolves to the formation of fibrotic
sequelae, permanently hindering the patient’s health.
P. brasiliensis Undergoes a Dimorphic Process in Vivo—It is
assumed that the fungus exists as a soil saprophyte, producing
propagules that can infect humans and produce disease after
transition to the pathogenic yeast form (4). Pathogenicity has
been intimately associated with this process, since P. brasilien-
sis strains unable to differentiate into the yeast form are avir-
ulent (5). Mammalian estrogens inhibit dimorphism, explain-
ing the lower incidence of disease in females (6). The mycelium-
to-yeast transition in P. brasiliensis is governed by the rise in
temperature that occurs upon contact of mycelia or conidia
with the human host. In vitro, it can be reversibly reproduced
by shifting the growth temperature between 22 and 36 °C.
Molecular events related to genes that control signal transduc-
tion, cell wall synthesis, and integrity are likely to be involved
in this dimorphic transition.
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Supplemental Material can be found at:
P. brasiliensis genome size was estimated to be 30 Mb (7).
A study of P. brasiliensis gene density suggests that this fun-
gus contains between 7,500 and 9,000 genes,2 which is in
agreement with the estimated gene number for ascomycete
fungi genomes.
Here are presented the results of an effort to achieve a
comprehensive metabolic view of the P. brasiliensis dimorphic
life cycle based on analysis of 6,022 groups generated from both
mycelium and yeast phases. This view arises from both a gen-
eral metabolism perspective and the identification of the pre-
cise metabolic points that distinguish both morphological
phases. Overexpressed genes and those that are up- or down-
regulated in both stages were identified. Expression levels
were assessed by cDNA microarrays and some were confirmed
by Northern blot. Drug targets and genes related to virulence
were also detected in several metabolic pathways. Finally, the
majority of genes involved in signal transduction pathways
(cAMP/protein kinase A, Ca2/calmodulin, and MAPKs) possi-
bly participating in cell differentiation and infection were an-
notated, and now we are able to describe the corresponding
signaling systems in P. brasiliensis.
MATERIALS AND METHODS
Fungus—P. brasiliensis isolate Pb01 (ATCC MYA-826) was grown
at either 22 °C in the mycelium form (14 days) or 36 °C as yeast (7
days) in semisolid Fava Neto’s medium. Following incubation, cells
were collected for immediate RNA extraction with Trizol reagent
(Invitrogen).
Construction of cDNA Libraries and Sequencing—Poly(A) mRNA
was isolated from total mycelium and yeast RNA through oligo(dT)-
cellulose columns (Stratagene). Unidirectional cDNA libraries were
constructed in ZAPII following supplier’s instructions (Stratagene).
Phagemids containing fungal cDNA were then mass-excised and repli-
cated in XL-1 Blue MRF cells. In order to generate ESTs, single pass
5-end sequencing of cDNAs was performed by standard fluorescence
labeling dye terminator protocols with T7 flanking vector primer. Sam-
ples were loaded onto a MegaBACE 1000 DNA sequencer (Amersham
Biosciences) for automated sequence analysis.
EST Processing Pipeline and Annotation—PHRED quality assess-
ment and computational analysis were carried out as previously de-
scribed (8). EST assembly was performed using the software package
CAP3 (9) plus a homemade scaffolding program. Sequences of at least
100 nucleotides, with PHRED 20, were considered for clustering. A
total of 20,271 ESTs were selected by these exclusion criteria. Contam-
inant and rRNA sequences were then removed to generate a set of
19,718 ESTs, which was submitted to CAP3 clustering, generating
2,655 contigs and leaving 3,367 ESTs as singlets. Contigs plus singlets
comprise the base set of 6,022 P. brasiliensis assembled EST sequences
(PbAESTs) that underwent further analysis. Annotation was carried
out using a system that essentially compared these assemblies with
sequences available in public databases. The BLASTX program (10)
was used for annotation along with GenBankTM nonredundant (nr),
cluster of orthologous groups (COG), and gene ontology (GO) data
bases. The GO data base was also used to assign EC numbers to
assemblies. Additionally, we used the FASTA program (11) to compare
assemblies with Saccharomyces cerevisiae and Schizosaccharomyces
pombe predicted polypeptides. The INTERPROSCAN program (12) was
used to obtain domain and family classification of the assemblies.
Metabolic pathways were analyzed using maps obtained in the KEGG
Web site (13) with annotated EC numbers, and this information was
used to help in assigning function to PbAESTs.
Differential Expression Analysis in Silico by Electronic Subtrac-
tion—To assign a differential expression character, the contigs formed
with mycelium and yeast ESTs were statistically evaluated using a test
previously described (14) with a confidence of 95%.
cDNA Microarrays and Data Analysis—A set of two microarrays
containing a total of 1,152 clones in the form of PCR products was
spotted in duplicate on 2.5  7.5-cm Hybond N nylon membranes
(Amersham Biosciences). Arrays were prepared using a Generation III
Array Spotter (Amersham Biosciences). Complementary DNA inserts of
both P. brasiliensis libraries were amplified in 96-well plates using
vector-PCR amplification with T3 forward and T7 reverse universal
primers. Membranes were first hybridized against the T3 [-33P]dCTP-
labeled oligonucleotide. The amount of DNA deposited in each spot was
estimated by the quantification of the obtained signals. After stripping,
membranes were used for hybridization against -33P-labeled cDNA
complex probes. The latter were prepared by reverse transcription of 10
g of filamentous or yeast P. brasiliensis total RNA using oligo(dT)12–18
primer. One hundred microliters of [-33P]cDNA complex probe (30–50
million cpm) was hybridized against nylon microarrays. Imaging plates
were scanned by a phosphor imager (Cyclone; Packard Instruments) to
capture the hybridization signals. BZScan software was employed to
quantify the signals with background subtraction. Spots were matched
with a template grid. The ratio between vector and cDNA complex probe
hybridization values for each spot was used as the reference normal-
ization value. Total intensity normalization using the median expres-
sion value was adopted as previously described (15). Gene expression
data analyzed here were obtained from three independent determina-
tions for each phase (filamentous or yeast). We used the significance
analysis of microarrays method (16) to assess the significant variations
in gene expression between both mycelium and yeast. Briefly, this
method is based on t test statistics, specially modified to high through-
put analysis. A global error chance, the false discovery rate, and a gene
error chance (q value) are calculated by the software.
Northern Blot Analysis—Total RNA (15 g) was separated in a 1.5%
denaturing formaldehyde agarose gel and transferred to a Hybond-N
nylon membrane (GE Healthcare). Probes were radiolabeled with the
random primers DNA labeling system (Invitrogen) using [-32P]dATP.
Membranes were incubated with the probes in hybridization buffer
(50% formamide, 4 SSPE, 5 Denhardt’s solution, 0,1% SDS, 100
g/ml herring sperm DNA) at 42 °C overnight and then washed twice
(2 SSC, 1% SDS) at 65 °C for 1 h. Signal bands were visualized using
a Typhoon 9210 phosphor imager (GE Healthcare).
URLs—Details of the results and raw data are available for down-
load from the World Wide Web: Pbgenome project Web site (www.bi-
omol.unb.br/Pb); Gene Ontology Consortium (www.geneontology.org);
Cluster of Ortologous Genes (www.ncbi.nlm.nih.gov/COG); INTER-
PROSCAN (www.ebi.ac.uk/interpro/); National Center for Biotechnology
Information (www.ncbi.nlm.nih.gov/); Kyoto Encyclopedia of Genes and
Genomes (www.genome.ad.jp/kegg); BZScan Software (tagc.univ-mrs.fr);
Audic and Claverie statistical test (telethon.bio.unipd.it/bioinfo/
IDEG6_form/); Significance Analysis of Microarrays method (www-
stat.stanford.edu/tibs/SAM/); Candida albicans data base (genolist.
pasteur.fr/CandidaDB/); genomes from Aspergillus nidulans and
Neurospora crassa (www.broad.mit.edu/annotation/fungi/aspergillus/).
RESULTS
Transcriptome Features—In sequencing the P. brasiliensis
transcriptome, EST data were generated from nonnormalized
cDNA libraries of mycelium and yeast cells. The size range of the
cDNA inserts ranged from 0.5 to 2.5 kb. Single pass 5 sequenc-
ing was performed on 25,598 cDNA clones, randomly selected
from both libraries. Upon removal of bacterial and rRNA contam-
inant sequences, a total of 19,718 high quality ESTs underwent
CAP3 assembly, yielding 2,655 contigs and 3,367 singlets, which
constitute the so-called 6,022 P. brasiliensis Assembled EST
(PbAEST) data base. Contigs presented an average size of 901 bp,
and the number of ESTs assembled into contigs varied from 2 to
657 in the largest one (PbAEST 1068), which corresponds to M51,
a previously reported P. brasiliensis mycelium-specific transcript
(17). Of the 6,022 PbAESTs, 4,198 (69.4%) showed a probable
homologue in GenBankTM, and 4,130 (68.3%) showed a fungus
homologue (Fig. 1A and Supplemental Table I). We had used
MIPS functional categories to classify 2,931 PbAESTs into 12
major groups. P. brasiliensis showed a slightly higher percentage
of PbAESTs (4%) related to cellular communication and signal
transduction (Fig. 1B) compared with S. cerevisiae functional
categorization (3.4%).
Highly and Differentially Expressed Genes—The 27 highly
transcribed genes found in the P. brasiliensis transcriptome,
using a cut-off of 50 reads, are shown in Supplemental Table II.
Some of them were previously reported (8). Also, up- and down-
regulated genes in mycelium and yeast cells were detected by
statistical comparison of the number of sequences in corre-
2 C. Reinoso, G. Nin˜o-Vega, G. San-Blas, and A. Dominguez (2003) IV
Congreso Virtual de Micologia, personal communication.
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sponding PbAESTs (Table I). In order to support the electronic
subtraction data, cDNAs from each phase were used to probe
cDNA microarrays membranes containing 1,152 clones, which
were selected based on the following criteria: (i) ESTs exclusive
for a particular morphotype; (ii) ESTs corresponding to genes
more expressed in mycelium or yeast cells; and (iii) some ESTs
equally expressed in both cell types. From the 1,152 clones, 328
genes were up-regulated during the dimorphic transition: 58 in
mycelium and 270 in yeast (data not shown).
The cDNA microarray experiment confirmed most of the
electronic subtraction data and also points out to new differen-
tially expressed genes. Among them, a subclass of about 40
up-regulated genes in mycelium and yeast are described in
Table I, which includes M51, M32, hydrophobin 1/2, the highly
expressed yeast PbY20 protein, and some other genes that have
previously been described as differentially expressed in P. bra-
siliensis by different approaches (17–20). Other key up-regu-
lated genes related to the metabolism of P. brasiliensis (Table
I) are described and discussed elsewhere in this work. Inter-
estingly, we have found a yeast phase preferentially expressed
gene that possibly encodes a previously characterized P. brasil-
iensis estradiol-binding protein (21), also described in C. albi-
cans and in other fungi (22). It is speculated that the interaction
of the 17--estradiol hormone with a cytoplasmic protein inhibits
the mycelium-to-yeast transition, explaining the lower incidence
of PCM in females.
Metabolic Overview—P. brasiliensis seems to be capable of
producing ATP from the classical pathways of glycolysis, alco-
hol fermentation, and oxidative phosphorylation, since alcohol
dehydrogenase, cytochrome genes, ATP synthase subunits, and
pyrophosphatase genes were annotated. All genes encoding
glycolytic enzymes were identified in both mycelium and yeast.
Genes corresponding to the citrate cycle enzymes and to the
components of complexes I, II, III, and IV were found, reflecting
the ability of the fungus to perform complete aerobic pyruvate
degradation and oxidative phosphorylation. Its putative capac-
ity to also grow in anaerobiosis was evidenced by the alterna-
tive conversion of pyruvate to ethanol. Last, it may be able to
utilize two-carbon sources in the form of acetate and ethanol
through the glyoxylate cycle and obtain sulfite and nitrite from
the environment.
In order to validate the carbon source utilization profile
predicted by the transcriptome data, two P. brasiliensis isolates
(Pb01 and Pb18) were grown in McVeigh-Morton minimum
medium supplemented with different carbon sources and
growth patterns were qualitatively evaluated (Supplemental
Table III). We observed that, in accordance to the transcrip-
tome analysis prediction, several mono- and disaccharides,
such as D-glucose, D-fructose, D-galactose, D-mannose, D-sorbi-
tol, -trehalose, maltose, and sucrose were indeed utilized. On
the other hand, the predicted assimilation of D-inositol was not
confirmed. Transcripts related to the consumption of L-sorbose
and L-lactose were not detected; in fact, P. brasiliensis was
unable to grown in L-sorbose as the sole carbon source. We
consider that the unpredicted fungal growth in L-lactose can be
explained by the fact that the P. brasiliensis cDNA libraries
were not constructed under induction conditions. The observa-
tion that fructose, galactose, and glycerol were only utilized by
Pb01 and not by Pb18 isolate may simply reflect strain biolog-
ical variability as previously observed (7). A detailed descrip-
tion of P. brasiliensis metabolism, including a list of PbAESTs,
is shown in Supplemental Table IV.
Differential Metabolism between Mycelium and Yeast—The
up-regulated genes encoding enzymes in mycelium and yeast
cells listed in Table I are highlighted in Fig. 2. The differential
expression pattern of these genes (with the exception of glucoki-
nase from mycelium cells) was confirmed by Northern blot anal-
ysis (Fig. 3). In general, the gene overexpression pattern suggests
that mycelium saprophytic cells possess an aerobic metabolism,
in contrast with yeast cells. Actually, mycelium up-regulated
genes correspond to the main regulatory points of the citrate
cycle, such as the genes coding for isocitrate dehydrogenase and
succinyl-CoA synthetase; this strongly suggests a metabolic
shunt to oxidative phosphorylation. Also, glucokinase is induced,
producing glucose 6-phosphate, which is possibly converted
through the oxidative pentose phosphate pathway to ribose
5-phosphate, and then to salvage pathways of purine and pyrim-
idine biosynthesis. In fact, this correlates well with the overex-
pression of adenylate kinase and uridine kinase genes. The ex-
cess of ribose 5-phosphate is probably converted to fructose
6-phosphate and glyceraldehyde 3-phosphate by the nonoxida-
tive pentose phosphate pathway catalyzed by the overexpressed
transaldolase. Those sugars are converted to pyruvate and
acetyl-CoA for the citrate cycle in aerobic conditions.
In contrast, P. brasiliensis yeast cells overexpress the genes
encoding alcohol dehydrogenase I and pyruvate dehydrogenase
E1 subunit (Table I and Fig. 3); the latter can be detected in
high levels in cultures of S. cerevisiae grown both anaerobically
FIG. 1. P. brasiliensis transcriptome characterization. A, distribution of blast best hit among organisms. Each PbAEST was tested against
the GenBankTM nr data base, and the best hit organism was computed. A PbAEST was considered as not assigned when the best hit exceed an
E value of 1010. B, functional categorization of the PbAESTs using MIPS classification. We included 2931 curator-reviewed annotations in this
analysis.
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and aerobically in the presence of ethanol (23). The carbohy-
drate metabolism is probably shifted toward ethanol produc-
tion, reflecting the anaerobic behavior of the yeast form as
previously reported (24). Several pathways that provide sub-
strates for the glyoxylate cycle are up-regulated in the yeast
cells (Table I and Fig. 3). First, isocitrate lyase redirects the
metabolic flow using ethanol and acetate as two-carbon sources
and generating oxaloacetate, which can be reconverted to glu-
TABLE I
Differentially expressed genes in mycelium and yeast cells detected by electronic subtraction and cDNA microarray analysis
The PbAESTs were analyzed as to their differential expression by two methods: a statistical analysis of the number of mycelium and yeast ESTs
clustered in each PbAEST (14) and a cDNA microarray analysis of 1,152 PbAESTs, chosen according to the electronic subtraction criteria. A
differential pattern of genes encoding enzymes was used in the analysis of the differential metabolism.
PbAEST EC number Annotated function
Number of
readsa p valueb -Fold changec Accession number/Best hit organism/E value
M Y
Mycelium up-regulated genes
1068 M51d,e 653 4 0.000000 41666.0 BE758605/P. brasiliensis /0.0
2274 4.4.1.5 Lactoylglutathione lyasee 75 0 0.000000 7.0 NP_105614.1/Mesorhizobium loti/
1e-11
2521 Hydrophobin 1d,f 56 0 0.000000 AAM88289.1/P. brasiliensis/2e-51
1789 HSP90 co-chaperonef 19 10 0.018169 CAD21185.1/N. crassa/4e-48
2509 1.15.1.1 Copper-zinc superoxide dismutasef 14 5 0.010801 Q9Y8D9/A. fumigatus/1e-68
2458 Unknownf 13 6 0.025336
2478 Hydrophobin 2d,f 9 0 0.000951 AAR11449.1/P. brasiliensis/2e-70
1287 1.13.11.32 2-nitropropane dioxygenasef 8 1 0.008606 CAB91335.2/N. crassa/e-133
1318 Amino acid permeasee 8 0 0.001907 50.4 CAD21063.1/N. crassa/0.0
1470 Unknowne 8 2 0.021572 20.1
2269 2.7.4.3 Adenylate kinasef 5 1 0.046263 NP_011097.1/S. cerevisiae/1e-42
2364 Unknowne 5 1 0.046263 3.6
379 Unknowne 5 1 0.046263 4.9
1092 4.2.1.22 Cystathionine -synthasef 4 0 0.030842 AAL09565.1/Pichia pastoris/4e-96
2356 2.2.1.2 Transaldolasef 4 0 0.030842 NP_013458.1/S. cerevisiae/e-108
2476 3.1.2.22 Palmitoyl-protein thioesterasef 4 0 0.030842 I58097/H. sapiens/8e-42
4135 1.1.1.41 Isocitrate dehydrogenaseg 1 0 0.248690 3.1 O13302/Acetobacter capsulatum/6e-
31
5530 6.2.1.5 -Succinyl CoA synthetaseg 1 0 0.248690 2.7 T49777/N. crassa/9e-73
4749 2.7.1.2 Glucokinaseg 1 0 0.248690 1.7 Q92407/Aspergillus niger/2e-50
4246 2.7.1.48 Uridine-kinaseg 1 0 0.248690 2.7 T41020/S. pombe/3e-28
Yeast up-regulated genes
2536 Y20 proteine,d 27 88 0.000000 8.7 AAL50803.1/P. brasiliensis/e-106
2431 1.1.1.1 Alcohol dehydrogenase If 2 45 0.000000 P41747/Aspergillus flavus/e-129
737 3.5.1.41 Xylanase/chitin deacetylasee 8 33 0.000023 2.8 NP_223015.1/Helicobacter pylori/
e-113
201 Putative membrane protein Nce2e 0 27 0.000000 25.2 NP_015475.1/S. cerevisiae/5e-08
797 3.1.6.6 Choline sulfatasee 3 15 0.001602 4.8 NP_248721.1/P. aeruginosa/e-104
814 Glyoxylate pathway regulatore 0 15 0.000016 17.7 NP_009936.1/S. cerevisiae/4e-37
1704 60S ribosomal protein L19f 0 14 0.000032 NP_596715.1/S. pombe/6e-49
1585 1.8.4.8 PAPS reductasee 1 12 0.000815 5.1 AAG24520.1/Penicillium
chrysogenum/e-121
63 Putative methyltransferasee 3 11 0.011314 2.5 CAD21381.1/N. crassa/2e-46
778 Putative estradiol-binding proteine 3 11 0.011314 29.5 NP_012049.1/S. cerevisiae/1e-31
136 Unknownd,f 4 10 0.030950 3.9
767 Unknowne 3 10 0.017732 2.2
701 1.2.4.1 Pyruvate dehydrogenasef 1 9 0.004973 Q10489/ S. pombe/1e-72
1724 Putative sterol transportere 0 6 0.007915 29.3 NP_013748.1/S. cerevisiae/4e-12
171 2.6.1.42 Branched-chain aminotransferasef 0 5 0.015790 NP_012078.1/S. cerevisiae/7e-87
1983 1.6.5.3 NADH dehydrogenase (ubiquinone
reductase)f
0 4 0.031496 S47150/N. crassa/1e-19
244 1.1.1.69 Gluconate dehydrogenasef 0 4 0.031496 NP_471610.1/Listeria innocua/
1e-09
258 3.3.2.1 Isochorismatasef 0 4 0.031496 NP_436193.1/Sinorhizobium
meliloti/1e-20
279 2.5.1.15 Dihydropteroate synthasef 0 4 0.031496 T49535/N. crassa/1e-38
314 2.6.1.1 Aspartate aminotransferasef 0 4 0.031496 NP_509047.1/Caenorhabditis
elegans/4e-96
555 6.2.1.3 Acyl-CoA synthetasef 0 4 0.031496 NP_275799.1/Methanothermobacter
thermautotrophicus/9e-89
756 6.3.5.7 Glutamyl-tRNA amidotransferasef 0 4 0.031496 Q33446/A. nidulans/1e-15
865 4.1.3.1 Isocitrate lyasef 0 4 0.031496 AAK72548.2/Coccidioides
immitis/e-119
963 2.6.1.9 Histidinol-phosphate aminotransferasef 0 4 0.031496 P36605/S. pombe/4e-87
980 3.5.1.4 Acetamidasef 0 4 0.031496 AAK31195.1/Aspergillus terreus/2e-
09
3073 1.14.13.3 Phenylacetate hydroxylaseg 0 1 0.249998 2.3 AAF21760.1/P. chrysogenum/2e-48
a Number of mycelium (M)- and yeast (Y)-derived ESTs in the PbAEST.
b p value for the Audic and Claverie test.
c -Fold change found for the microarray experiments.
d Previously shown to be differential by Northern blot or proteome analysis.
e Electronic subtraction and cDNA microarray analysis; differential pattern in both analyses.
f Electronic subtraction differential pattern and not assayed in cDNA microarray analysis.
g Singlets that are differential in cDNA microarray analysis.
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cose. In addition, the branched-chain aminotransferase gene is
also overexpressed (as are other aminotransferase genes, such
as those of aspartate and histidinol-P) and converts valine,
leucine, and isoleucine to acetyl-CoA, which is then fed to the
cycle. The yeast differential acetamidase also contributes to
this pathway by deriving acetate from acetamide. Further-
more, the up-regulated acyl-CoA synthetase generates acetyl-
CoA in the first step of -oxidation, which may also be taken up
by the cycle. Finally, the generation of sulfite by phospho-
adenylyl sulfate reductase provides acetate for the glyoxylate
cycle as mentioned above. The overall analysis suggests that
ATP production through alcohol fermentation and the respira-
tory chain occurs in a biased pattern, the former being prefer-
ential in the yeast form and the latter in mycelium.
Yeast cells are rich in chitin; the high expression of chitin
deacetylase reveals its possible involvement in cell wall loos-
ening, reorganization, and synthesis of newly components dur-
ing cell growth and budding of yeast cells. This enzyme is not
present in humans and thus represents a possible drug target.
In mycelium, overexpression of cystathionine -synthase and
nitroalkane oxidase strongly suggests that mycelium cells take
up sulfite and nitrogen, respectively, from the environment for
metabolic processing. Finally, the probable role of the remain-
ing overexpressed gene encoding palmitoylthioesterase re-
mains unclear. In contrast, the enzymes isochorismatase and
ubiquinone-reductase are greatly up-regulated in the yeast
form, strongly suggesting a high production of ubiquinone by
P. brasiliensis, which could be involved in cellular oxidative
stress under anaerobic conditions. The high yeast expression of
dihydropteroate synthase produces, as a consequence, high
levels of tetrahydrofolate, which probably will increase the
metabolic flow toward purine biosynthesis. The meaning of the
high expression in yeast of choline sulfatase, gluconate dehy-
drogenase, glutamyl-tRNA amidotransferase, and phenylac-
etate hydroxylase also remains unclear.
Cell Cycle and Genetic Information—The main genes in-
FIG. 2. Comparison of the expression pattern of genes encoding for enzymes in mycelium-to-yeast cell differentiation of
P. brasiliensis. For the detailed metabolic comparison between mycelium and yeast metabolism, see Supplemental Table IV, since we have
presented in this figure only the central pathways for carbohydrate metabolism and citrate cycle. Genes that are overexpressed are boxed, either
in mycelium or yeast cells, according to the criteria described in Table I.
FIG. 3. Northern blot analysis of mycelium and yeast up-regulated genes of P. brasiliensis. Total RNA samples from both mycelium (M)
and yeast (Y) were blotted onto nylon membranes and hybridized against gene-specific radiolabeled probes. ICDH, isocitrate dehydrogenase; SCS,
-succinyl-CoA-synthetase, TAL, transaldolase; ADK, adenylate kinase; UDK, uridylate kinase; ICL, isocitrate lyase; acyl-CS, acyl-CoA synthe-
tase; PDH, pyruvate dehydrogenase; ADH, alcohol dehydrogenase; PAPsR, phosphoadenylyl sulfate reductase; ACA, acetamidase; AMT, amino-
transferase. The constitutive 60 S ribosomal protein L34 was used as a loading control.
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volved in cell cycle and in the basic genetic information flow
machinery (DNA replication, repair, recombination, transcrip-
tion, RNA processing, translation, and post-translational mod-
ifications) are well conserved in comparison with their coun-
terparts from S. cerevisiae. Also, sequences related to
mitochondrial replication, budding, sporulation, and mating
were also annotated (Supplemental Table V).
From the cell cycle-related orthologues identified in P. bra-
siliensis, those related to the structure and assembly of the
cytoskeleton, chromatin structure, chromosome segregation,
cyclins, and cell cycle control genes were highlighted. Genes
related to the major DNA repair mechanisms found in yeast
(mismatch, base excision, and recombination systems) were
identified in P. brasiliensis, although not every component was
represented, since cells were not subjected to DNA-damaging
conditions. The RAD52 gene, which plays an essential role in
S. cerevisiae recombination, is also present in the P. brasilien-
sis transcriptome.
Among the identified transcription factors, the orthologues
for MAT, MCM1, and NsdD are of relevance, since they are
implicated in ascomycete sexual reproduction. These genes rep-
resent a strong evidence for mating in P. brasiliensis, so far not
yet described, which is reinforced by the detection of six tran-
scripts involved in meiotic recombination.
Stress Responses—Cell differentiation in P. brasiliensis re-
quires a temperature shift, which might be associated with a
stress response. We have found 48 sequences encoding molec-
ular chaperones and their associated co-chaperones in P. bra-
siliensis transcriptome (Supplemental Table VI). These se-
quences were divided into nine groups: small chaperones (four
genes), HSP40 (9), HSP60 (10), HSP70 (7), HSP90 (4), HSP100
(4), 14-3-3 (2), calnexin (1), and immunophilins (7). Eight of
these are differentially expressed: calnexin, cct7 (cytoplasmic
hsp60) and sba1 (HSP90/70 co-chaperone) for the mycelium
form and cpr1 (HSP90/70 co-chaperone), hsp42, hsp60, ssc1
(HSP70), and hsp90 for the yeast form. From these, hsp60 and
hsp70 had been previously characterized as differentially ex-
pressed in yeast (25, 26). cDNA microarray analysis confirmed
the differential expression pattern of sba1. Furthermore, the
number of chaperone and co-chaperone ESTs is 38% larger in
the yeast cDNA library than in the mycelium library. These
data represent an evidence of an altogether higher expression
of HSPs in yeast cells, compatible with growth at 37 °C.
Oxidative agents may cause stress and damage to P. brasil-
iensis cells. They may originate from the activity of host macro-
phages or from intracellular oxidative species. P. brasiliensis
contains several genes encoding enzymes with known or puta-
tive antioxidant properties, such as superoxide dismutases,
catalases (two isoenzymes), peroxiredoxins, and a novel cyto-
chrome c peroxidase (Supplemental Table VII). Homologues to
genes encoding secondary antioxidant enzymes belonging to
the glutathione S-transferase family were also found. Several
transcription factors may be involved in the induction of anti-
oxidant defenses in P. brasiliensis. Homologues to YAP1,
HAP3, and SKN7 from S. cerevisiae (27) were discovered in the
transcriptome, showing that the oxidative stress regulators
from P. brasiliensis and baker’s yeast might be conserved.
Signal Transduction Pathways—Transcriptome analysis
and reverse annotation revealed several putative components
of the biosignaling pathways in P. brasiliensis (Supplemental
Table VIII), such as (i) MAPK signaling for cell integrity, cell
wall construction, pheromone/mating, and osmotic regulation;
(ii) cAMP/protein kinase A, regulating fungal development and
virulence, and (iii) calcium-calmodulin-calcineurin, controlling
growth at high temperature. Furthermore, a ras homologue
sequence was detected raising the possibility of cross-talk
among the distinct signal transduction pathways (Fig. 4).
In budding yeast, the MAPK cascade responsible for cell
integrity mediates cell cycle regulation and cell wall synthesis,
responding to different signals including temperature, changes
in external osmolarity, and mating pheromone. Components of
this pathway identified in P. brasiliensis encompass the most
classical steps, with the exception of a cell surface tyrosine
kinase-like receptor that was not found in the transcriptome so
far analyzed. Rho1p is a small GTP-binding protein of the Rho
subfamily required for cell growth and coordinated regulation
of cell wall construction (28) through the synthesis of -1,3-
glucan. It also activates Pkc1p, which in turn regulates the
MAPK pathway.
Transcripts related to the pathway for activation by mating
pheromone were identified in the P. brasiliensis transcriptome.
The intermediary components appear to be constitutively ex-
pressed in both mycelium and yeast forms. Intriguingly, mat-
ing has not yet been described in P. brasiliensis. Conversely,
the Hog1 MAPK cascade is activated when there is an increase
in the environment osmolarity. One of its targets, Glo1p, which
controls genes required for cell adaptation and survival upon
osmotic stress in S. cerevisiae (29), was also detected in
P. brasiliensis.
The cAMP/protein kinase A is a cascade known to regulate
fungal differentiation and virulence. From the genes identified
in P. brasiliensis, we highlight a homologue to several fungal
adenylate cyclases; the low affinity cAMP phosphodiesterase,
encoded by the gene Pde1; homologues to both the regulatory
and the catalytic subunits of protein kinase A, which is in-
volved in the regulation of the cell surface flocculin Flo11p/
Muc1p (30). In P. brasiliensis exogenous cAMP is known to
inhibit the process of filamentation (31). Both the catalytic
(CnaA) and the Ca2-binding regulatory B (CnaB) subunits of
calcineurin were found in P. brasiliensis. In dimorphic fungi,
cAMP- and calcineurin-dependent pathways seem to be in-
volved in differentiation. As in the pathogenic fungus Crypto-
coccus neoformans (32), calcineurin might also play a role in
mating of P. brasiliensis. In several pathogenic and nonpatho-
genic fungi, RAS is involved in filamentation, pseudohyphal/
hyphal growth, and mating (33). A RAS-related transcript was
identified in P. brasiliensis, but further studies are required to
elucidate its function in mycelium-to-yeast transition and in
the mechanism of pathogenicity.
Virulence Genes, Drug Targets and Resistance—In order to
identify genes that could be related to P. brasiliensis virulence,
its transcriptome has been searched for orthologues assigned
as virulence factors in human pathogenic fungi, as defined by
Falkow’s postulate (34). Table II lists 28 P. brasiliensis se-
quences, which were previously experimentally established as
virulence or essential genes in C. albicans, C. neoformans, and
Aspergillus fumigatus. They were subdivided into four classes:
metabolism-, cell wall-, and signal transduction-related and
others. Some of these genes has been considered for antifungal
therapy and are also listed in Table III as potential drug
targets.
MAPK-related sequences, whose orthologues in C. albicans
were experimentally correlated to hyphal formation and viru-
lence, were also detected. The extrapolation to the P. brasilien-
sis model is not direct, since yeast, not hyphae, is the patho-
genic cell type, but several MAPK homologues are found in
species exhibiting diverse morphology and infection habits (35).
A cavps34 orthologue, identified in P. brasiliensis transcrip-
tome (vps34), is implicated in the protein/lipid transport from
the Golgi apparatus/endosome to the vacuole and has been
proved to be important to C. albicans virulence (36).
Noteworthy is the finding of glyoxylate cycle genes in
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P. brasiliensis, since its activity has been reported as a fungal
virulence requirement (37). The activity of the key enzymes
malate synthase and isocitrate lyase was reported to be up-
regulated in C. albicans upon phagocytosis (38). Both enzymes
were detected in the P. brasiliensis transcriptome, with isoci-
trate lyase being overexpressed in the yeast phase, as con-
firmed by Northern blot analysis (Fig. 3).
The cell wall, as the most obvious difference between human
and fungal cells, represents a prime target for antifungals.
Genes involved in its biogenesis and assembly can act as viru-
lence factors and therefore are putative drug targets. We have
identified orthologues to chitin synthase 3 (chs3), glucosamine-
6-phosphate acetyltransferase (gna1), mannosyltransferase
(pmt1), and 1,2-mannosyltransferase (mnt1) genes and glyco-
sidases Phr1p and Phr2p. The expression of the two last genes
in C. albicans is responsive to the product of prr2 (39), a
pH-related transcription factor also present in the P. brasilien-
sis transcriptome. The detection of chitin deacetylase, as an
overexpressed yeast gene confirmed by cDNA microarray and
Northern blot (data not shown), points out to a novel target for
drug research in P. brasiliensis.
Microbe resistance to reactive oxygen and nitrogen interme-
diates plays an important role in virulence (40). We were able
to identify sequences that are oxidative stress response ortho-
logues, including an alternative oxidase (aox1), a copper/zinc
superoxide dismutase (sod1), and two different catalase ortho-
logues, one of them a peroxisomal cat1, as recently described
(41).
The urate oxidase gene detected in the P. brasiliensis tran-
scriptome, but not in S. cerevisiae, C. albicans, and Homo
sapiens genomes, suggests that uric acid could be degraded to
allantoin. In addition, the presence of a C. neoformans urease
orthologue also probably reflects the degradation of urea to
ammonia and carbamate. A role in virulence and sporulation
has been assigned for both genes (42). The production of urea
has been involved in an improved in vitro survival for those
microorganisms exposed to an acidic environment. In this view,
it could be related to the survival of the fungus in the host cells.
The development of new drugs is crucial, considering the
problem of emerging drug resistance and toxicity (37). Novel
drug targets have been found through the analysis of genome
sequences. The genes listed in Table III have no homologues in
the human genome and therefore could be considered for the
development of new antifungal drugs. Most therapies designed
to treat fungal infections target the ergosterol biosynthetic
pathway (43). The orthologue of C-24 sterol methyltransferase
(ERG6) is present in P. brasiliensis. In addition, modulation of
sphingolipid metabolism exerts a deep impact on cell viability.
The synthesis of inositol-phosphoryl-ceramide from phytocer-
amide catalyzed by the product of the aur1 gene, present in
P. brasiliensis, corresponds to the first specific step of this
pathway (44). Translation elongation factors have also been
pointed out as drug targets (37). In the P. brasiliensis tran-
scriptome, we have found an elongation factor-3 sequence that
is absent in human genome (45) and thus can be addressed for
pharmaceutical purposes.
Twenty PbAESTs annotated as related to multiple drug re-
sistance genes were identified (Supplemental Table IX). They
include 12 S. cerevisiae orthologues, 10 of which are related to
the ABC transporter and two to major facilitator superfamilies
(46). One of them corresponds to Pfr1, a gene recently described
in P. brasiliensis (47), and another is related to the CDR1 gene
from C. albicans, which is up-regulated in the presence of
human steroid hormones (48). It has been speculated that
FIG. 4. Signaling pathways in P. brasiliensis. Shown are cAMP/protein kinase A regulating fungal development and virulence; MAPK
signaling for cell integrity, cell wall construction, pheromone/mating, and osmoregulation; calcium-calmodulin-calcineurin controlling cell survival
under stress conditions; and Ras allowing cross-talk of extracellular signals. For abbreviations of gene names see Supplemental Table VIII.
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steroid hormones are involved in morphological changes as well
as in pathogenicity in P. brasiliensis and also in drug resistance
in C. albicans. Interestingly, the process of infection of
P. brasiliensis is strongly biased toward males, albeit the role
of steroid hormones in the expression of ABC transporters in
this organism remains to be investigated.
DISCUSSION
The P. brasiliensis transcriptome described here is repre-
sented by 6,022 EST clusters that may cover about 80% of the
fungal total genome, whose gene number has been estimated to
be 8,000 genes.3 This number greatly exceeds the previous
EST studies in this fungus (8, 49). The analysis compares the
two fungal cell types as well as their metabolic behavior. The
results obtained probably reflect the adaptations associated
with the mycelium (soil) and yeast (human host) environments.
Most importantly, they provide new insights with respect to
3 G. San-Blas, personal communication.
TABLE II
Putative virulence or essential genes found in P. brasiliensis transcriptome related to the experimentally confirmed orthologues
of C. albicans, C. neoformans, and/or A. fumigatus
PBAEST Orthologuename AC number/Organism E value
a Remarks
Metabolic genes
2403 ura3b DCCKA (C. albicans) 3e-41
O13410 (A. fumigatus) 2e-83
0670 nmtb AAA34351 (C. albicans) 8e-60 Lipid synthesis
AAA17547 (C. neoformans) 1e-60
3750 fas2b JC4086 (C. albicans) 7e-33
1224 hem3 094048 (C. albicans) 1e-58 Hemosynthesis
3819 tps1b CAA69223 (C. albicans) 1e-36 Glucose metabolism
1693 icl1 AAF34690 (C. albicans) 1e-112 Glyoxylate cycle
0831 mls1 AAF34695 (C. albicans) 1e-122 Glyoxylate cycle
1735 pabaAb AAD31929 (A. fumigatus) 1e-12 Purine synthesis
Cell wall genes
4346 chs3 P30573 (C. albicans) 7e-22 Potential drug targets
4968 gna1b BAA36496 (C. albicans) 4e-16
1067 mnt1 CAA67930 (C. albicans) 9e-49
2980 pmt1 AAC31119 (C. albicans) 4e-46
2382 phr1 AAF73430 (C. albicans) 2e-40*
1375 phr2 AAB80716 (C. albicans) 1e-114
Signal transduction
4452 cek1 A47211 (C. albicans) 3e-30 Hyphal formation
1110 cpp1 P43078 (C. albicans) 6e-16
267 cst20 AAB38875 (C. albicans) 6e-48
358 hog1b Q92207 (C. albicans) 2e-59 Osmoregulation
988 nik1b AAC72284 (C. albicans) 7e-37 Hyphal development
Other fungal virulence
determinant genes
623 cat1b CAA07164 (C. albicans) 1e-172 Peroxisomal catalase
3553 mdr1b CAA76194 (C. albicans) 2e-27
3306 plb1b AAF08980 (C. albicans) 2e-38 Important in host cell penetration
4267 top1b Q00313 (C. albicans) 4e-56
5012 vps34b CAA70254 (C. albicans) 2e-29 Vesicle trafficking
2516 sod1b AAK01665 (C. neoformans) 4e-51 Nitric oxide detoxification
2463 ure1b AAC62257 (C. neoformans) 6e-76
1102 aox1b AAM22475 (C. neoformans) 2e-48 Resistance to oxidative stress
a All P. brasiliensis assembled ESTs are BBH with C. albicans ortologues, except phr1 (marked with an asterisk).
b Putatively novel P. brasiliensis virulence genes.
TABLE III
Potential drug targets genes found in P. brasiliensis transcriptome with no homologues in the human genome
PbAEST Annotated function Orthologue accessionnumbers E-value Remarks
Cell wall
5198 -1,3-glucan synthase AAD37783 2e-108 Preferentially expressed in mycelium
4988 -1,3-glucan synthase AAL18964 2e-70 Preferentially expressed in yeast
0265 Rho AAK08118 2e-92 Signal transduction
1147 Chitin synthase I AAF82801 2e-81
1927 Chitin synthase II Q92444 3e-66
4346 Chitin synthase IV AF107624 2e-65
3958 Chitin synthase asmA JC5546 1e-64
0737 Xylanase/Chitin deacetylase ZP_00126582 1e-12 Up-regulated in P. brasiliensis yeast cells
5473 Bud neck involved NP_014166 1e-12 Required to link CHS3p and CHS4p to the septins
1063 -1,2-Mannosyltransferase NP_009764 1e-20 Involved in protein glycosylation
Glyoxylate cycle
2402 Malate synthase P28344 1e-37
1688 Isocitrate lyase AAK72548.2 1e-144 Up-regulated in P.brasiliensis yeast cells
Other targets
1959 (24)-Sterol C-methyltransferase T50969 4e-44 Ergosterol biosynthesis
0200 Aureobasidin resistance protein AAD22750 1e-43 Sphingolipid synthesis
0845 Elongation factor 3 BAA33893 1e-142 Unique and essentially required for fungal
translational machinery
4129 Urate oxidase P33282 6e-77 Sporulation and pathogenesis
2456 Urease AAC49868 3e-94 Sporulation and pathogenesis
P. brasiliensis Mycelium and Yeast Transcriptional Profiles 24713










signal transduction pathways, virulence genes, and drug tar-
gets for this pathogen.
The transcription profile of the mycelium infective phase
suggests the shunting of pyruvate into aerobic metabolism,
since the expression of the ESTs encoding enzymes of the
trichloroacetic acid cycle are up-regulated in this fungal phase.
In contrast, the yeast transcription profile evidenced the devi-
ation of pyruvate from the glycolytic pathway into anaerobic
metabolism; this observation is consistent with a lower oxygen
level in infected tissues. Its putative ability to produce ethanol
suggests a potential anaerobic pathway for P. brasiliensis,
which is dependent on the metabolic state of the cell. It seems
that the main regulatory effector on the shunting of the end
product of glycolysis into aerobic or anaerobic metabolism is
temperature; therefore, it can be hypothesized that this phys-
ical factor is the central trigger of all of these molecular events,
since it was the only parameter changed in the in vitro culti-
vation of yeast and mycelium of P. brasiliensis. Experiments
are currently being carried out in order to confirm the in vivo
expression profile of the differentially expressed genes in
macrophages and human pulmonary epithelial cells infected by
P. brasiliensis.
Since P. brasiliensis is a medical problem in Latin America,
the prediction of new drug targets from sequence information is
of great importance. Chitin deacetylase, which is absent in
humans and highly expressed in the parasitic yeast, could be a
specific drug target for PCM therapy if it is shown to play a key
role in the fungal metabolism during human infection. Func-
tional analysis of the P. brasiliensis genes described in this
work will lead to important information on cellular differenti-
ation, pathogenicity, and/or virulence. These issues can only be
addressed when molecular tools are developed for this orga-
nism. In conclusion, the knowledge of the transcribed se-
quences of P. brasiliensis will most likely facilitate the devel-
opment of new therapeutics to PCM and other medically
relevant mycosis.
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